Backed by over two decades of expertise in stem cell biology, Accellta has revolutionized cell culture technology. We are the first in the world to develop and refine a platform enabling large-scale growth of pluripotent stem cells—without microcarriers, scaffolds, or genetic modification. Our non-GMO technology, built on extensive experience with embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), maintains cells’ natural behaviour during cultivation.
Our Technology
Pioneering Scalable Cell Culture for Global Solutions
Our proprietary 3D suspension culture platform
Designed by expert stem cell biologists, supports both the efficient production of undifferentiated stem cells and their controlled differentiation into specialized cell types. By harnessing our deep understanding of cellular behavior, we can direct cells toward specific outcomes, meeting diverse industry needs.
Our technology has led to groundbreaking developments
Accellta’s technology and expertise have led to the development of a cultivation process for the production of cultivated human red blood cells from stem cells for RedC Biotech.
Producing milk fat from cow stem cells, offering a sustainable alternative to traditional dairy production
By leveraging our expertise, Accellta's platform accelerates large-scale production, offering unmatched efficiency for applications in biopharma, regenerative medicine, and sustainable food-tech.
We remain committed to solving today's challenges and shaping the future of biotechnology through scalable cell culture solutions.
Contact Us
Thank you for your interest, please let us know how we can help you